In February of 2021, a 42-year-old woman was referred to our ocular surface disease clinic with ongoing symptoms of dry eye following her SARSCoV2 (Covid) infection in late 2019, which she had contracted in Hong Kong and had made her quite unwell.
Premium subscriber content
Sign in if you have a Digital or Print + Digital subscription. Don’t have one yet? Digital subscribers get full access to this article from $40/year +GST.
- Premium exclusive content
- Full digital magazine archive
- Early access to new articles
- 11 print magazine issues per year
